Baxter Highlights Innovations At AORN Global Surgical Conference
13 Apr 2026 //
PHARMIWEB
Baxter To Host Annual Meeting Of Stockholders In Virtual Format
25 Mar 2026 //
PHARMIWEB
Baxter Announces CFO Transition
16 Mar 2026 //
BUSSINESSWIRE
Baxter Reports Fourth-Quarter 2025 Results
12 Feb 2026 //
PHARMIWEB
Baxter Reports Early Tender Results For Senior Notes Due 2026
04 Dec 2025 //
PHARMIWEB
Baxter Reports Third-Quarter 2025 Results
30 Oct 2025 //
BUSINESSWIRE
Baxter Hosts Q3 2025 Financial Results Conference Call
15 Oct 2025 //
PHARMIWEB
Baxter`s Second-Quarter 2025 Results Released
31 Jul 2025 //
BUSINESSWIRE
Baxter Names Andrew Hider as CEO
07 Jul 2025 //
BUSINESSWIRE
Baxter Taps New CEO as It Emerges from Years-Long Restructuring
07 Jul 2025 //
FIERCE BIOTECH
Baxter to Present at Goldman Sachs Healthcare Conference 2025
27 May 2025 //
BUSINESSWIRE
Baxter Declares Quarterly Dividend
06 May 2025 //
BUSINESSWIRE
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
20 Feb 2025 //
BUSINESSWIRE
Baxter to Host Q4 2024 Financial Results Call for Investors
22 Jan 2025 //
BUSINESSWIRE
Baxter Announces Five Injectable Product Launches in the U.S.
11 Dec 2024 //
BUSINESSWIRE
Baxter Reports Third-Quarter 2024 Results
08 Nov 2024 //
BUSINESSWIRE
Baxter exits China IV fluids market amid US shortage
30 Oct 2024 //
FIERCE PHARMA
Baxter expects to restart IV fluids line at hurricane-hit
24 Oct 2024 //
REUTERS
Hurricane-related IV fluid shortage could hurt medical device makers
17 Oct 2024 //
REUTERS
Baxter to import 18,000 tons of IV products to US by year-end
17 Oct 2024 //
REUTERS
Baxter imports IV fluids as Hurricane Helene triggers U.S. shortage
14 Oct 2024 //
REUTERS
Baxter offers recovery timeline at storm-hit IV fluid facility
09 Oct 2024 //
FIERCE PHARMA
Fresenius to boost output after hurricane damage at rival Baxter
08 Oct 2024 //
REUTERS
Vizient Shares Strategies For Potential IV Fluid Supply Disruption
07 Oct 2024 //
BUSINESSWIRE
Baxter unsure when NC plant will recover after hurricane damage
04 Oct 2024 //
FIERCE PHARMA
Baxter to Present at 2024 Wells Fargo Healthcare Conference
28 Aug 2024 //
BUSINESSWIRE
Carlyle to buy Baxter`s kidney-care spinoff Vantive for $3.8 billion
14 Aug 2024 //
REUTERS
Baxter To Sell Vantive Kidney Care Segment To Carlyle For $3.8 Billion
13 Aug 2024 //
BUSINESSWIRE
Carlyle in talks to buy Baxter`s kidney care unit
06 Jul 2024 //
REUTERS
Baxter HDx Dialysis Tied To ~25% Lower Mortality For Up To 4 Years
29 May 2024 //
BUSINESSWIRE
Baxter unveils plummy new branding for kidney care spinout Vantive
17 May 2024 //
FIERCE PHARMA
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
15 May 2024 //
BUSINESSWIRE
Baxter Secures FDA Approval For Clinolipid Neonatal, Pediatric Indication
13 May 2024 //
BUSINESSWIRE
Baxter Declares Quarterly Dividend
07 May 2024 //
BUSINESSWIRE
Baxter Reports First-Quarter 2024 Results
02 May 2024 //
BUSINESSWIRE
Baxter AnnouncesFDA Clearance of Novum Infusion Pump and Dose IQ Safety Software
01 Apr 2024 //
BUSINESSWIRE
Spectral Medical Announces Extension of Distribution Agreement With Baxter
21 Feb 2024 //
GLOBENEWSWIRE
Baxter Declares Quarterly Dividend
14 Nov 2023 //
BUSINESSWIRE
Baxter Reports Third-Quarter 2023 Results
02 Nov 2023 //
BUSINESSWIRE
Baxter Appoints Joel Grade Chief Financial Officer
03 Oct 2023 //
BUSINESSWIRE
Baxter Announces Updates to Its Board of Directors
21 Aug 2023 //
BUSINESSWIRE
Baxter beats sales estimates on strong demand for medical devices
27 Jul 2023 //
REUTERS
Baxter dubs its upcoming kidney care spinoff Vantive
25 Jul 2023 //
FIERCE BIOTECH
Baxter Announces Strategic Actions to Enhance Operational Effectiveness
06 Jan 2023 //
BUSINESSWIRE
Middle East and Africa Alzheimer`s Disease Therapeutics & Diagnostics Market
20 Dec 2022 //
BUSINESSWIRE
Baxter to Host Third-Quarter 2022 Financial Results Conference for Investors
07 Sep 2022 //
BUSINESSWIRE
Baxter Healthcare announces new APAC leader
21 Jul 2022 //
BIOSPECTRUMASIA
U.S. FDA labels Baxter`s respiratory device recall as most serious
24 Jun 2022 //
REUTERS
Baxter issues warning for lung expansion therapy device
03 Jun 2022 //
FIERCEBIOTECH
Baxter Highlights Business Strategies & Innovation at 2022 Investor Conference
25 May 2022 //
BUSINESSWIRE
Baxter Reports First-Quarter 2022 Results
28 Apr 2022 //
BUSINESSWIRE
Baxter to Host Q1 2022 Financial Results Conference Call for Investors
23 Mar 2022 //
BUSINESSWIRE
Baxter reaches $18M settlement with SEC over accounting errors
24 Feb 2022 //
FIERCEBIOTECH
Baxter Reports Fourth-Quarter and Full-Year 2021 Results
17 Feb 2022 //
BUSINESSWIRE
Baxter begins integrating Hillrom, faces supply chain pressures
17 Feb 2022 //
MEDTECHDIVE
Baxter to Present at Citi’s 2022 Virtual Healthcare Conference
10 Feb 2022 //
BUSINESSWIRE
Novartis-backed ImmPACT Bio $111M ex-Baxter, Pfizer exec new CEO
19 Jan 2022 //
FIERCEBIOTECH
Baxter to Host Q4 2021 Financial Results Conference Call for Investors
06 Jan 2022 //
BUSINESSWIRE
Baxter Reports Third-Quarter 2021 Results
28 Oct 2021 //
BUSINESSWIRE
Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR CCL14 Test
21 Oct 2021 //
BIOSPACE

Market Place
Sourcing Support